Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Source: TechCrunch
🔑 Key Takeaways
- Wire dispatch directly ingested from TechCrunch.
- Published at Wed, 14 Oct 2026 23:00.
- Source URL: https://techcrunch.com/2026/10/14/intero-biosystems-wants-drugmakers-to-test-on-mini-human-intestines-not-animals/